Skip to content
naulon
Not checkedNot checked for notices yet.

A live attenuated strain of HY9901ΔdctP provides protection against Vibrio alginolyticus to the pearl gentian grouper (♀Epinephelus fuscoguttatus × ♂Epinephelus lanceolatus)

Yilin Zhang, Yilin Zhang, Ziyu Zhang and 12 more

Frontiers in Marine Science · 2022

doi:10.3389/fmars.2022.907407 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

In recent decades, vibriosis caused by Vibrio alginolyticus has become a severe threat to the global mariculture industry. There is an urgent need for an effective vaccine to alleviate this unoptimistic situation. In this study, we evaluated the safety, immunoprotection, and specific and non-specific immune response effect of ΔdctP strain as a live-attenuated vaccine to pearl gentian grouper (♀Epinephelus fuscoguttatus × ♂Epinephelus lanceolatu). The results demonstrate that the safe dose of ΔdctP was ≤1.0 ×106 CFU in pearl gentian grouper. The relative percent survival of the pearl gentian grouper challenged with the ΔdctP mutant strain by intraperitoneal injection reached 74.4%, which was significantly higher than that of the control group. Meanwhile, the expression level of immune-relative genes, including IgM, IL-1β, IL-8, IL-10, MHC-Iα, MHC2, TNF-α, TLR3, and CD4, were upregulated in liver, spleen, and head kidney within 28 d post-vaccination. Moreover, specific antibody IgM, total serum protein as well as activities of catalase, superoxide dismutase, and lysozyme in serum were significantly up-regulated in vaccinated groupers compared with those in control. Collectively, ΔdctP could be used as a live-attenuated vaccine candidate against V. alginolyticus infection in pearl gentian grouper.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.